Companies: 10,795·Total market cap: $144.5T
Boston Scientific Corporation

Boston Scientific Corporation

BSXNYSEHealthcare● Active
$48.66
+$0.11(+0.23%)
Market Cap$72.3B
P/E Ratio
52W High$109.5
52W Low$47.17
Overview

Boston Scientific Corporation (BSX) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · BSX · as of Jun 8, 2026

Activity summary

Buy transactions

4

P-Purchase only

Sell transactions

18

12 Months

Buy/Sell ratio

0.22

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 18%Active transactions only · RSU vesting excluded82% Sell ↓

Boston Scientific Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

BSX insider buying and selling by quarter

BSX insider selling · BSX insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
1.0M516K0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · BSX ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

BSX executive sell shares · BSX board member insider trading · BSX insider trading SEC filing

Showing 69 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Mahoney Michael F

Chairman, President & CEO · Director

Gift

Date

May 28

Shares

386,755

Price

Value

View Form 4 on SEC.gov

Pegus Cheryl

Director

Purchase

Date

May 20

Shares

1,770

Price

$56.49

Value

$100K

View Form 4 on SEC.gov

LUDWIG EDWARD J

Director

Purchase

Date

May 20

Shares

3,580

Price

$56.68

Value

$203K

View Form 4 on SEC.gov

Habiger David C

Director

Purchase

Date

May 20

Shares

2,250

Price

$55.92

Value

$126K

View Form 4 on SEC.gov

Habiger David C

Director

Purchase

Date

May 19

Shares

2,200

Price

$56.95

Value

$125K

View Form 4 on SEC.gov

Zane Ellen M

Director

Award

Date

May 7

Shares

3,800

Price

Value

View Form 4 on SEC.gov

WICHMANN DAVID S

Director

Award

Date

May 7

Shares

3,800

Price

Value

View Form 4 on SEC.gov

Weber Christophe Pierre

Director

Award

Date

May 7

Shares

1,140

Price

Value

View Form 4 on SEC.gov

Weber Christophe Pierre

Director

Award

Date

May 7

Shares

1,767

Price

Value

View Form 4 on SEC.gov

Morano Susan E

Director

Award

Date

May 7

Shares

1,281

Price

Value

View Form 4 on SEC.gov

Morano Susan E

Director

Award

Date

May 7

Shares

3,800

Price

Value

View Form 4 on SEC.gov

Mega Jessica L

Director

Award

Date

May 7

Shares

3,800

Price

Value

View Form 4 on SEC.gov

LUDWIG EDWARD J

Director

Award

Date

May 7

Shares

3,800

Price

Value

View Form 4 on SEC.gov

Habiger David C

Director

Award

Date

May 7

Shares

3,800

Price

Value

View Form 4 on SEC.gov

O'Connor Padraig Andrew

EVP, Global Operations

Option

Date

May 2

Shares

1,802

Price

Value

View Form 4 on SEC.gov

O'Connor Padraig Andrew

EVP, Global Operations

Other

Date

May 2

Shares

872

Price

$56.50

Value

$49K

View Form 4 on SEC.gov

Butcher Arthur C

EVP& Grp Pres, MedSurg & APAC

Option

Date

May 2

Shares

2,102

Price

Value

View Form 4 on SEC.gov

Butcher Arthur C

EVP& Grp Pres, MedSurg & APAC

Other

Date

May 2

Shares

1,007

Price

$56.50

Value

$57K

View Form 4 on SEC.gov

Morano Susan E

Director

Award

Date

Mar 2

Shares

24

Price

Value

View Form 4 on SEC.gov

Weber Christophe Pierre

Director

Award

Date

Mar 2

Shares

323

Price

Value

View Form 4 on SEC.gov

Weber Christophe Pierre

Director

Award

Date

Mar 2

Shares

556

Price

Value

View Form 4 on SEC.gov

Woodworth Emily

SVP, Global Controller and CAO

Option

Date

Mar 1

Shares

838

Price

Value

View Form 4 on SEC.gov

Woodworth Emily

SVP, Global Controller and CAO

Other

Date

Mar 1

Shares

372

Price

$76.85

Value

$29K

View Form 4 on SEC.gov

Butcher Arthur C

EVP& Grp Pres, MedSurg & APAC

Other

Date

Feb 19

Shares

6,851

Price

$75.76

Value

$519K

View Form 4 on SEC.gov

O'Connor Padraig Andrew

EVP, Global Operations

Option

Date

Feb 16

Shares

905

Price

Value

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About BSX insider trading

BSX insider trades

Boston Scientific Corporation (BSX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Mahoney Michael F (Chairman, President & CEO · Director), O'Connor Padraig Andrew (EVP, Global Operations), Butcher Arthur C (EVP& Grp Pres, MedSurg & APAC). Over the past 12 months, 5 insiders have filed transactions with the SEC. BSX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Boston Scientific Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

BSX insider trading · 5 questions

The insiders of Boston Scientific Corporation (BSX) include executives and directors such as Mahoney Michael F (Chairman, President & CEO · Director), O'Connor Padraig Andrew (EVP, Global Operations), Butcher Arthur C (EVP& Grp Pres, MedSurg & APAC), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

BSX board member insider tradingwho are BSX insidersBSX insider rosterBoston Scientific Corporation executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026